3 ms·
It’s a good thing the specific criticism of this trial is that they didn’t use the most effective vaccine for 65+ people, since you’re concerned about having th
by alex43578 9mo ago
It’s a good thing the specific criticism of this trial is that they didn’t use the most effective vaccine for 65+ people, since you’re concerned about having the most effective vaccines.
- watwut 9mo agoSo, the majority of us, people under 65 are completely unaffected. And yes, the vaccine can be approved for 65- while not approved for 65+.
- alex43578 9mo agoThe fall 2025 approval was limited to 65+/preexisting conditions. If this vaccine wasn’t being tested for 65+, it might not be approved at all based on that.
- altcognito 9mo agoHow do you know if you don’t do a study? You can call anything a criticism, but it doesn’t make it true.